Status:
COMPLETED
Metabolic Effects of Cocaine
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Cocaine Dependence
Eligibility:
All Genders
21-49 years
Phase:
NA
Brief Summary
The goal of this this study is to elucidate the role of the HPA axis in the pathophysiology of cocaine dependence
Eligibility Criteria
Inclusion
- Individuals with DSM IV diagnosis of cocaine dependence, medically healthy
Exclusion
- Other than cocaine dependence DSM-IV axis I diagnosis
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00451230
Start Date
June 1 2005
End Date
June 1 2005
Last Update
January 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02116